Community Trust & Investment CO Biogen Inc. Transaction History

Community Trust & Investment CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 26, 2021	SELL	$236.26 - $355.63 $166,799 - $251,074	-706 Closed	0 $0
Q3 2020 Oct 21, 2020	BUY	$264.77 - $305.71 $186,927 - $215,831	706 New	706 $200,000
Q2 2020 Jul 21, 2020	SELL	$258.66 - $342.55 $182,613 - $241,840	-706 Closed	0 $0
Q4 2019 Jan 10, 2020	BUY	$220.06 - $304.07 $155,362 - $214,673	706 New	706 $209,000
Q2 2019 Jul 17, 2019	SELL	$219.29 - $241.72 $312,707 - $344,692	-1,426 Closed	0 $0
Q4 2018 Jan 16, 2019	SELL	$278.5 - $352.75 $1,949 - $2,469	-7 Reduced 0.49%	1,426 $429,000
Q3 2018 Nov 01, 2018	BUY	$293.51 - $383.83 $2,054 - $2,686	7 Added 0.49%	1,433 $506,000
Q1 2018 Apr 20, 2018	SELL	$260.13 - $367.91 $2,081 - $2,943	-8 Reduced 0.56%	1,426 $390,000
Q4 2017 Jan 26, 2018	BUY	$307.64 - $344.58 $2,461 - $2,756	8 Added 0.56%	1,434 $457,000
Q3 2017 Nov 03, 2017	BUY	$281.15 - $329.69 $400,919 - $470,137	1,426	1,426 $447,000

1,038

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Community Trust & Investment CO, based on Form 13F filings with the SEC.

Stay updated on Community Trust & Investment CO with notifications on news.